Table 1 White blood cell counts profiles between patients and matched healthy controls in AQP4-IgG-positive NMOSD and MOGAD.
Patients | 1:5 matched controls | P-values | |
|---|---|---|---|
AQP4-IgG-positive NMOSD (Patient group: n = 13 vs matched controls: n = 65) | |||
Total WBC count | 6700 (4810–7440) | 5500 (4500–6100) | 0.0723 |
Hemoglobin [g/dL] | 14.1 (13.6–14.5) | 13.4 (12.7–14.2) | 0.1955 |
Platelet count [103/μL] | 24.8 (21.4–31.2) | 25.8 (22.3–29.0) | 0.8986 |
Neutrophil [/μL] | 4520 (2880–5280) | 3260 (2710–3720) | 0.0247 |
Eosinophil [/μL] | 50 (20–80) | 110 (50–170) | 0.0111 |
Basophil [/μL] | 10 (10–30) | 30 (20–40) | 0.0283 |
Lymphocyte [/μL] | 1230 (1140–1720) | 1690 (1350–2060) | 0.0511 |
Monocyte [/μL] | 290 (250–380) | 240 (180–300) | 0.0359 |
PLR | 175.2 (138.5–198.3) | 149.1 (125.8–190.0) | 0.1315 |
MLR | 0.229 (0.157–0.248) | 0.139 (0.110–0.162) | 0.0004 |
NLR | 3.134 (1.835–4.485) | 1.899 (1.438–2.381) | 0.0037 |
MOGAD (Patient group: n = 26 vs matched controls: n = 130) | |||
Total WBC count | 6350 (5550–7380) | 5200 (4430–6350) | 0.0001 |
Hemoglobin [g/dL] | 13.8 (12.6–14.8) | 13.7 (12.8–14.6) | 0.8753 |
Platelet count [10^3/μL] | 26.0 (22.9–31.6) | 24.4 (21.0–28.1) | 0.0578 |
Neutrophil [/μL] | 4040 (3230–5090) | 2960 (2390–3700) | < 0.0001 |
Eosinophil [/μL] | 90 (60–190) | 110 (70–200) | 0.5927 |
Basophil [/μL] | 30 (20–50) | 30 (20–40) | 0.3415 |
Lymphocyte [/μL] | 1860 (1600–2220) | 1750 (1520–2140) | 0.4965 |
Monocyte [/μL] | 320 (240–360) | 250 (210–310) | 0.0191 |
PLR | 150.5 (113.1–185.0) | 134.9 (107.7–166.5) | 0.1799 |
MLR | 0.164 (0.138–0.196) | 0.146 (0.116–0.179) | 0.0320 |
NLR | 2.169 (1.788–3.072) | 1.692 (1.355–2.108) | 0.0002 |
